Sumitomo Chemical India Ltd. delivered robust financial performance in the June quarter, with net profit surging 20.5% year-on-year to ₹214.8 crore compared to ₹178.3 crore in the corresponding period last year. According to reports from CNBC TV18 and Business Standard, the agrochemical company's strong bottom-line growth demonstrates effective operational management despite modest revenue growth. The latest Q1FY27 results show standalone net profit rising 20.4% to ₹2,165.29 million and consolidated net profit increasing 20.5% to ₹2,148.30 million, as reported by the company in its unaudited financial statements approved by the Board of Directors on July 27, 2026. The company's board met on July 27, 2026, alongside its 26th AGM to review these results, with unverified alert figures suggesting a ~19.4% year-on-year rise in net profit, though official exchange filings are required for confirmation.
Revenue from operations showed marginal growth, increasing 0.6% year-on-year to ₹1,063.3 crore from ₹1,056.7 crore in the year-ago period. As reported by CNBC TV18 and Business Standard, this modest revenue expansion indicates a challenging operating environment where the company managed to improve profitability through operational efficiency improvements. The latest Q1FY27 results confirm this trend with consolidated revenue from operations growing marginally by 0.6% to ₹10,633.46 million compared to the prior year period. The company's full year FY26 consolidated revenue reached ₹4,140.98 crore, demonstrating the company's ability to maintain stable revenue streams despite industry challenges. Total income for Q1 FY27 reached ₹11,106.30 million, compared to ₹10,955.65 million in Q1 FY26 and ₹7,159.16 million in Q4 FY26.
The company's operating performance showed significant improvement with EBITDA rising 6.1% to ₹217.7 crore from ₹205 crore in the corresponding quarter last year. According to CNBC TV18, EBITDA margin expanded to 20.48% from 19.40% a year ago, indicating enhanced operational efficiency and better cost management across the business. The latest Q1FY27 results demonstrate even stronger margin expansion with consolidated EBITDA improving to ₹2.3 billion from ₹2.2 billion in the same quarter last year, and EBITDA margin expanding to 22% from 20.74% year-on-year. Full year FY26 consolidated EBITDA margin stood at 20.7%, while the company's net profit margin reached 16.8% for the full year, reflecting strong operational leverage. Business Standard reports show operating profit margin (OPM) improved to 21.94% in Q1 FY27 from 20.74% in the previous year, with PBDT rising 9% to ₹278.57 crore and PBT increasing 9% to ₹261.34 crore.
The profit growth was significantly boosted by exceptional items rather than core operational expansion. The company recorded a ₹268.96 million gain from an insurance claim for business interruption due to a fire incident at its Bhavnagar plant during FY23. Excluding this one-time gain, the core operational profit before tax was ₹2,643.65 million (standalone), reflecting steady underlying performance. This compares favorably to the prior year which saw a ₹151.86 million exceptional charge related to new labour codes, highlighting the volatility from regulatory and non-operational factors. The company's working capital cycle extended as net working capital days increased from 89 days to 103 days as of March 31, 2026, due to strategic inventory building to support future growth initiatives.
Sumitomo Chemical India is undergoing a significant leadership transition with Dr. Suresh Ramachandran's appointment as Managing Director approved to take effect from September 1, 2026. The company's board meeting on July 27, 2026, coincided with the 26th AGM, marking a crucial governance milestone. Additionally, a strategic capital expenditure plan for Dahej was approved in early 2026 to manufacture herbicide intermediates for the Japanese parent company, indicating clear long-term focus on deepening integration with the global supply chain. The company's basic and diluted EPS for Q1 FY27 stood at ₹4.30, compared to ₹3.57 in Q1 FY26, reflecting improved earnings per share. The company's credit rating was reaffirmed by CRISIL as CRISIL AA/Stable for its bank loan facilities of ₹200 crore, providing financial stability as it navigates the upcoming leadership transition and strategic expansion initiatives.
